Botfet / Company detail

SYK

approved

Stryker Corporation

biotech

Moat score66out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic8.5%

Gross Margin64.0%

Revenue Cagr10.1%

Fcf Conversion131.9%

Fcf Yield3.7%

Interest Coverage10.4x

Market Cap B$116.9B

Pe31.6

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant66

Why it may endure

Moat breakdown

Quant: 66 · Curator: 0

Market Share Stability18

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener